PharmaCyte Biotech, Inc. Business Finance Contracts & Agreements
42 Contracts & Agreements
- Note Agreements (1 contract)
- Purchase Agreements (8)
- Registration Rights Agreements (4)
- Release Agreements (1)
- Share Agreements (1)
- Stock Agreements (10)
- Term Sheets (1)
- Underwriting Agreements (1)
- Warrant Agreements (15)
- Registration Rights Agreement, dated May 20, by and among PharmaCyte Biotech, Inc. and MyMD Pharmaceuticals, Inc (Filed With SEC on May 23, 2024)
- Form of Short-Term Warrant of MyMD Pharmaceuticals, Inc (Filed With SEC on May 23, 2024)
- Form of Long-Term Warrant of MyMD Pharmaceuticals, Inc (Filed With SEC on May 23, 2024)
- Form of Certificate of Designations of Series G Convertible Preferred Stock of MyMD Pharmaceuticals, Inc (Filed With SEC on May 23, 2024)
- Securities Purchase Agreement, dated May 20, by and among PharmaCyte Biotech, Inc. and MyMD Pharmaceuticals, Inc (Filed With SEC on May 23, 2024)
- Form of Registration Rights Agreement (Filed With SEC on November 16, 2023)
- Form of Convertible Note (Filed With SEC on November 16, 2023)
- Form of Purchase Agreement (Filed With SEC on November 16, 2023)
- Form of Series B Warrant (Filed With SEC on November 16, 2023)
- Form of Series A Warrant (Filed With SEC on November 16, 2023)
- Form of Registration Rights Agreement (Filed With SEC on May 11, 2023)
- Form of Purchase Agreement (Filed With SEC on May 11, 2023)
- Form of Warrant (Filed With SEC on May 11, 2023)
- Release Agreement, dated October 12, 2022, by and between PharmaCyte Biotech, Inc. and Gerald W. Crabtree (Filed With SEC on October 14, 2022)
- Securities Purchase Agreement, dated as of August 19, 2021 (Filed With SEC on August 23, 2021)
- Form of Placement Agent Common Stock Purchase Warrant (Filed With SEC on August 23, 2021)
- Form of Series A Warrant Common Stock Purchase Warrant (Filed With SEC on August 23, 2021)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on August 23, 2021)
- Form of Underwriters Warrant (Filed With SEC on August 12, 2021)
- Form of Pre-funded Warrant (Filed With SEC on August 12, 2021)
- Form of Common Warrant (Filed With SEC on August 12, 2021)
- Underwriting Agreement, dated as of August 9, 2021 (Filed With SEC on August 12, 2021)
- Share Subscription Agreement between the Company and the Investor dated January 17, 2020 (Filed With SEC on January 21, 2020)
- Fourth Amendment to Asset Purchase Agreement between the Company, S.G. Austria Pte. Ltd. and Austrianova Singapore Pte. Ltd. effective May 14, 2018 (Filed With SEC on May 15, 2018)
- Binding Term Sheet between Austrianova Singapore Pte. Ltd. andSG Austria Pte. Ltd. and PharmaCyte Biotech, Inc. (Filed With SEC on September 6, 2017)
- THIRD STOCK OPTION AGREEMENT (Filed With SEC on March 8, 2016)
- THIRD STOCK OPTION AGREEMENT (Filed With SEC on March 8, 2016)
- STOCK AND WARRANT PURCHASE AGREEMENT (Filed With SEC on January 12, 2016)
- STOCK AND WARRANT PURCHASE AGREEMENT (Filed With SEC on January 12, 2016)
- PHARMACYTE BIOTECH, INC. COMMON STOCK WARRANT AGREEMENT (Filed With SEC on January 12, 2016)
- PHARMACYTE BIOTECH, INC. COMMON STOCK WARRANT AGREEMENT (Filed With SEC on January 12, 2016)
- Second stock option agreement (Filed With SEC on March 13, 2015)
- FIRST stock option agreement (Filed With SEC on March 13, 2015)
- SECOND stock option agreement (Filed With SEC on March 13, 2015)
- FIRST stock option agreement (Filed With SEC on March 13, 2015)
- stock option agreement (Filed With SEC on October 3, 2014)
- stock option agreement (Filed With SEC on October 3, 2014)
- stock option agreement (Filed With SEC on October 3, 2014)
- ASSET PURCHASE AGREEMENT (Filed With SEC on September 25, 2014)
- PURCHASE AGREEMENT (Filed With SEC on February 19, 2014)
